• Home
  • XARELTO-Reducing the Risk of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation (AF) and for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism

XARELTO-Reducing the Risk of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation (AF) and for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism

  • 03/10/2016
  • 6:15 PM
  • Wildwood Restaurant

Registration

  • This dinner presentation is open to all KCMS members. Each KCMS member may bring one licensed medical worker as a guest.

Registration is closed

All KCMS Members are invited to join their colleagues for the KCMS Learning Event on XARELTO (rivaroxaban) presented by Dr. Azmey Matarieh, FACC, MD from Advocate Health Institute, in Elgin. 

This presentation is being sponsored by Janssen Pharmaceuticals, Inc. and per PhRMA guidelines only licensed medical workers may attend this program. 

Copyright © 2015 KCMS. All rights reserved.
Reproduction in whole or in part without permission is prohibited.

Powered by Wild Apricot Membership Software